Live Breaking News & Updates on Sonic Healthcare Australia Pathology

Microba and Sonic Healthcare have now signed a commercial agreement to deliver Microba’s advanced infectious disease testing technology MetaPanel™ into Australia



This new metagenomic diagnostic test has been designed to identify a comprehensive panel of pathogenic microorganisms and genes to advance the standard of care in gastrointestinal infectious disease pathology



This is the first executed agreement between Microba and Sonic Healthcare (ASX: SHL) since Sonic Healthcare acquired a 19.99% equity holding in Microba and marks the first stage of the parties delivering Microba’s world leading microbiome testing technology into Sonic Healthcare’s major markets.



A video presentation of this announcement by Microba CEO Dr Luke Reid can be viewed here https://ir.microba.com/presentations/ ....

New Zealand , United States , United Kingdom , Microba Metapanel , Douglass Hanley Moir , Paul Griffin , Luke Reid , Douglass Hanly Moir Pathology Pty Ltd , Microba Life Sciences Limited , Sonic Healthcare Limited , Metapanel Technology , Microba Life Sciences , First Distribution Agreement Executed , Sonic Healthcare , Life Sciences Limited , Distribution Agreement , Sonic Healthcare Australia Pathology , Chief Executive Officer , Sonic Healthcare Douglass Hanley Moir , Professor Paul Griffin , Infectious Diseases , Mater Hospital , Life Sciences , Australian Organ Transplant , Business Wire ,